Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impact of CYP2C19 polymorphisms on the clinical action of proton pump inhibitors (PPIs).

× No keyword cloud information.

14 in total

1. Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status.

Authors: Mitsushige Sugimoto; Takahisa Furuta; Naohito Shirai; Masayoshi Kajimura; Akira Hishida; Masaharu Sakurai; Kyoichi Ohashi; Takashi Ishizaki
Journal: Clin Pharmacol Ther Date: 2004-10 Impact factor: 6.875

2. Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.

Authors: Paul A Gurbel; Wei C Lau; Udaya S Tantry
Journal: J Am Coll Cardiol Date: 2008-01-22 Impact factor: 24.094

Review 3. Proton pump inhibitors: an update of their clinical use and pharmacokinetics.

Authors: Shaojun Shi; Ulrich Klotz
Journal: Eur J Clin Pharmacol Date: 2008-08-05 Impact factor: 2.953

4. A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.

Authors: Sarah C Sim; Carl Risinger; Marja-Liisa Dahl; Eleni Aklillu; Magnus Christensen; Leif Bertilsson; Magnus Ingelman-Sundberg
Journal: Clin Pharmacol Ther Date: 2006-01 Impact factor: 6.875

5. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects.

Authors: Jean-Sébastien Hulot; Alessandra Bura; Eric Villard; Michel Azizi; Véronique Remones; Catherine Goyenvalle; Martine Aiach; Philippe Lechat; Pascale Gaussem
Journal: Blood Date: 2006-06-13 Impact factor: 22.113

6. Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data.

Authors: Matthias Schwab; Ulrich Klotz; Ute Hofmann; Elke Schaeffeler; Andreas Leodolter; Peter Malfertheiner; Gerhard Treiber
Journal: Clin Pharmacol Ther Date: 2005-12 Impact factor: 6.875

Review 7. Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.

Authors: U Klotz
Journal: Int J Clin Pharmacol Ther Date: 2006-07 Impact factor: 1.366

Review 8. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.

Authors: J Horn
Journal: Aliment Pharmacol Ther Date: 2004-11 Impact factor: 8.171

9. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Authors: Martine Gilard; Bertrand Arnaud; Jean-Christophe Cornily; Grégoire Le Gal; Karine Lacut; Geneviève Le Calvez; Jacques Mansourati; Dominique Mottier; Jean-François Abgrall; Jacques Boschat
Journal: J Am Coll Cardiol Date: 2008-01-22 Impact factor: 24.094

10. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.

Authors: Dietmar Trenk; Willibald Hochholzer; Martin F Fromm; Ligia-Emilia Chialda; Andreas Pahl; Christian M Valina; Christian Stratz; Peter Schmiebusch; Hans-Peter Bestehorn; Heinz Joachim Büttner; Franz-Josef Neumann
Journal: J Am Coll Cardiol Date: 2008-05-20 Impact factor: 24.094

4 in total

Review 1. Refractory chronic cough due to gastroesophageal reflux: Definition, mechanism and management.

Authors: Han-Jing Lv; Zhong-Min Qiu
Journal: World J Methodol Date: 2015-09-26

2. A stepwise protocol for the treatment of refractory gastroesophageal reflux-induced chronic cough.

Authors: Xianghuai Xu; Hanjing Lv; Li Yu; Qiang Chen; Siwei Liang; Zhongmin Qiu
Journal: J Thorac Dis Date: 2016-01 Impact factor: 2.895

3. PK/PD modeling of rabeprazole in CYP2C19 genotypes: consideration of the influence of thio-ether metabolite, CYP3A4, accumulation and CYP2D6 polymorphism may help to better develop and validate the model.

Authors: Nuggehally R Srinivas
Journal: Eur J Clin Pharmacol Date: 2011-03-19 Impact factor: 2.953

4. Pharmacokinetics and Pharmacodynamics of Esomeprazole/Sodium Bicarbonate Immediate-Release Capsules in Healthy Chinese Volunteers: A Cross-Over, Randomized Controlled Trial.

Authors: Shan Jing; Yue Zhu; Wenfang Liu; Kexu Yang; Lili Hu; Dan Deng; Chunyan Lu; Yang Lin
Journal: Adv Ther Date: 2021-02-11 Impact factor: 3.845

4 in total